uric acid and tbc-11251

uric acid has been researched along with tbc-11251 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dhaun, N; Goddard, J; Johnston, NR; Webb, DJ1
Benza, RL; Dhaun, N; Hwang, LJ; Liu, X; Naeije, R; Teal, S; Vachiery, JL; Webb, DJ1

Trials

2 trial(s) available for uric acid and tbc-11251

ArticleYear
Chronic selective endothelin A receptor antagonism reduces serum uric acid in hypertensive chronic kidney disease.
    Hypertension (Dallas, Tex. : 1979), 2011, Volume: 58, Issue:2

    Topics: Cross-Over Studies; Double-Blind Method; Endothelin A Receptor Antagonists; Hypertension; Hyperuricemia; Isoxazoles; Kidney Failure, Chronic; Thiophenes; Treatment Outcome; Uric Acid

2011
Endothelin antagonism and uric acid levels in pulmonary arterial hypertension: clinical associations.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2014, Volume: 33, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Bosentan; Child; Dose-Response Relationship, Drug; Double-Blind Method; Endothelin Receptor Antagonists; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Isoxazoles; Male; Middle Aged; Prospective Studies; Sulfonamides; Survival Rate; Thiophenes; Time Factors; Treatment Outcome; United States; Uric Acid; Young Adult

2014